TY - JOUR
T1 - Linkage-Editing Pseudo-Glycans
T2 - A Reductive α-Fluorovinyl-C-Glycosylation Strategy to Create Glycan Analogs with Altered Biological Activities
AU - Moriyama, Takahiro
AU - Yoritate, Makoto
AU - Kato, Naoki
AU - Saika, Azusa
AU - Kusuhara, Wakana
AU - Ono, Shunsuke
AU - Nagatake, Takahiro
AU - Koshino, Hiroyuki
AU - Kiya, Noriaki
AU - Moritsuka, Natsuho
AU - Tanabe, Riko
AU - Hidaka, Yu
AU - Usui, Kazuteru
AU - Chiba, Suzuka
AU - Kudo, Noyuri
AU - Nakahashi, Rintaro
AU - Igawa, Kazunobu
AU - Matoba, Hiroaki
AU - Tomooka, Katsuhiko
AU - Ishikawa, Eri
AU - Takahashi, Shunji
AU - Kunisawa, Jun
AU - Yamasaki, Sho
AU - Hirai, Go
N1 - Publisher Copyright:
© 2024 American Chemical Society
PY - 2024/1/24
Y1 - 2024/1/24
N2 - The acetal (O-glycoside) bonds of glycans and glycoconjugates are chemically and biologically vulnerable, and therefore C-glycosides are of interest as more stable analogs. We hypothesized that, if the O-glycoside linkage plays a vital role in glycan function, the biological activities of C-glycoside analogs would vary depending on their substituents. Based on this idea, we adopted a “linkage-editing strategy” for the creation of glycan analogs (pseudo-glycans). We designed three types of pseudo-glycans with CH2 and CHF linkages, which resemble the O-glycoside linkage in terms of bond lengths, angles, and bulkiness, and synthesized them efficiently by means of fluorovinyl C-glycosylation and selective hydrogenation reactions. Application of this strategy to isomaltose (IM), an inducer of amylase expression, and α-GalCer, which activates iNKT cells, resulted in the discovery of CH2-IM, which shows increased amylase production ability, and CHF-α-GalCer, which shows activity opposite that of native α-GalCer, serving as an antagonist of iNKT cells.
AB - The acetal (O-glycoside) bonds of glycans and glycoconjugates are chemically and biologically vulnerable, and therefore C-glycosides are of interest as more stable analogs. We hypothesized that, if the O-glycoside linkage plays a vital role in glycan function, the biological activities of C-glycoside analogs would vary depending on their substituents. Based on this idea, we adopted a “linkage-editing strategy” for the creation of glycan analogs (pseudo-glycans). We designed three types of pseudo-glycans with CH2 and CHF linkages, which resemble the O-glycoside linkage in terms of bond lengths, angles, and bulkiness, and synthesized them efficiently by means of fluorovinyl C-glycosylation and selective hydrogenation reactions. Application of this strategy to isomaltose (IM), an inducer of amylase expression, and α-GalCer, which activates iNKT cells, resulted in the discovery of CH2-IM, which shows increased amylase production ability, and CHF-α-GalCer, which shows activity opposite that of native α-GalCer, serving as an antagonist of iNKT cells.
UR - http://www.scopus.com/inward/record.url?scp=85182581877&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85182581877&partnerID=8YFLogxK
U2 - 10.1021/jacs.3c12581
DO - 10.1021/jacs.3c12581
M3 - Article
C2 - 38196121
AN - SCOPUS:85182581877
SN - 0002-7863
VL - 146
SP - 2237
EP - 2247
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 3
ER -